The origin of antibiotic resistance determinants is of significant interest for several reasons, including the prediction of the emergence and spread of resistance patterns, the design of new antimicrobial agents, and the identification of potential reservoirs for resistance elements. Antibiotic resistance can occur either through spontaneous mutation in the target or by the acquisition of external genetic elements such as plasmids or transposons which carry resistance genes (7). The origins of these acquired genes are varied, but it has long been recognized that potential reservoirs are antibiotic-producing organisms which naturally harbor antibiotic resistance genes to protect themselves from the actions of toxic compounds (6).
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High-level resistance to glycopeptide antibiotics such as vancomycin and teicoplanin in vancomycin-resistant enterococci (VRE) is conferred by the presence of three genes, vanH, vanA (or vanB), and vanX, which, along with auxiliary genes necessary for inducible gene expression, are found on transposons integrated into plasmids or the bacterial genome (1, 20) . These three genes are essential to resistance and serve to change the C-terminal peptide portion of the peptidoglycan layer from
This change results in the loss of a critical hydrogen bond between vancomycin and the D-Ala-D-Ala terminus and in a 1,000-fold decrease in binding affinity between the antibiotic and the peptidoglycan layer, which is the basis for the bactericidal action of this class of compounds (5) . The vanH gene encodes a D-lactate dehydrogenase which provides the requisite D-Lac (3, 5) , while the vanX gene encodes a highly specific DD-peptidase which cleaves only D-Ala-D-Ala produced endogenously while leaving D-Ala-D-Lac intact (19, 21) . The final gene, vanA or vanB, encodes an ATP-dependent D-Ala-D-Lac ligase (4, 8, 10) . This enzyme has sequence homology with the chromosomal D-Ala-D-Ala ligases, which are essential for peptidoglycan synthesis but which generally lack the ability to synthesize D-Ala-D-Lac (9 (15, 16) . We now report the expression of the A. orientalis C329.2 VanA homologue DdlN in Escherichia coli, its purification, and its enzymatic characterization. These data reinforce the striking similarity between vancomycin resistance elements in VRE and glycopeptide-producing organisms and support the possibility of a common origin for these enzymes. Expression, purification, and specificity of DdlN. DdlN was overexpressed in E. coli under the control of the bacteriophage T7 promoter. The construct gave good yields of highly purified enzyme following a four-step purification procedure (Table 1 Characterization of D-Ala-D-X ligase activity. Following the initial assessment of the specificity of the enzyme, several substrates were selected for quantitative analysis by evaluation of their steady-state kinetic parameters (Table 2) . DdlN has two amino acid (or hydroxy acid) K m values. Steady-state kinetic plots indicated that, like other DD-ligases, the N-terminal K m (K m 1) was significantly lower (higher specificity) than the Cterminal K m (K m 2). Since the former value is expected to be independent of the C-terminal substrate, only K m 2 values were determined and are reported here.
DdlN showed good D-Ala-D-Ala ligase activity but with a very high and physiologically questionable K m 2 (21 mM). On the other hand, D-Ala-D-Lac synthesis was excellent, with a 4-fold decrease in k cat , compared to D-Ala-D-Ala synthesis, which was offset by a 52-fold drop in K m that resulted in a Ͼ12-fold increase in specificity (k cat /K m 2). D-Hbut was also a good substrate, with a k cat /K m 2 comparable to that of D-Ala.
Steady-state kinetic parameters for D-Ala-D-X formation showed trends similar to those found with both VanA and DdlN. For example, the k cat values between VanA and DdlN were virtually the same for most substrates. There were significant differences, however. For instance, while the K m 2 values for D-Ala were very high for all three enzymes, DdlN does have greater affinity for D-Ala, with a 1.8-and 7.9-fold lower K m 2 than those of VanA and DdlM, respectively. Additionally, the K m 2 for D-Lac was 17.8-and 2.7-fold lower than those for VanA and DdlM. Thus, DdlN has a more restrictive specificity for the C-terminal residue than VanA, which is compensated for by a higher affinity for the critical substrate D-Lac.
pH dependence of peptide versus that of depsipeptide synthesis activity. The partitioning of the syntheses of D-Ala-DAla and D-Ala-D-Hbut in VanA and other depsipeptide-competent DD-ligases has been shown to be pH dependent (17) . Determination of the pH dependence of DdlN in synthesizing peptide versus depsipeptide (Fig. 3) directly paralleled the results obtained with VanA in similar experiments. At lower pHs (Ͻ7), D-Ala-D-Hbut synthesis predominates and is exclusive at a pH of Ͻ6 (Fig. 3) . At pH 7.5, levels of synthesis of D-Ala-DHbut and D-Ala-D-Ala are relatively equal, while at a pH greater than 8, the capacity to synthesize peptide overtakes the capacity to synthesize depsipeptide, although the latter is never abolished.
The partitioning of the formation of peptide versus depsipeptide as a function of pH by DdlM is comparable to that by VanA and depsipeptide-competent mutants of DdlB (17), which show essentially exclusively depsipeptide formation at lower pHs and increasing peptide formation as the pH increases. This implies a potential role for the protonated ammonium group of D-Ala2 in second-substrate recognition and suggests a mechanism for the discrimination between D-Ala and D-Lac at physiologic pH. The structural basis for this distinction remains obscure for DdlB and VanA or DdlN.
Concluding remarks. Resistance to vancomycin and other glycopeptides is mediated through the synthesis of a peptidoglycan which does not terminate with the canonical D-Ala-DAla dipeptide. Thus, enterococci which exhibit the VanC phenotype, which consists of low-level, noninducible resistance to vancomycin only, have peptidoglycan terminating in D-Ala-DSer (19) . On the other hand, bacteria which are constitutively resistant to high concentrations of glycopeptides, such as lactic (18) . On the other hand, the molecular basis for depsipeptide synthesis by the VanA or VanB ligases is unknown, in large part due to the lack of protein structural information on which to base mutational studies, unlike the situation with D-Ala-DAla ligases, where the E. coli DdlB structure serves as a template for mechanistic research (11).
Significantly, a major difference in the VanA or VanB ligases and other DD-ligases lies in the amino acid sequence of the -loop region, which closes off the active site of DdlB (11) and has been shown to contribute amino acid residues with the capacity to control the syntheses of D-Ala-D-Ala and D-Ala-DLac, notably, Tyr216 (17, 18) . Until recently, the VanA and VanB ligases were exceptional in amino acid structure and had no known homologues. The sequencing of resistance genes from glycopeptide-producing bacteria has uncovered enzymes with Ͼ60% homology to VanA or VanB and which are virtually superimposable in the critical -loop region (14, 15 (14) suggests that it may.
These studies demonstrate that DdlN cloned from a vancomycin-producing bacterium is a D-Ala-D-Lac ligase which has not only amino acid sequence homology with the DD-ligases from VRE but also functional homology. Thus, VanA, VanB, DdlN, and DdlM have likely evolved from similar origins. The fact that a vanH-vanA-vanX gene cluster can be found in other glycopeptide producers as well (14) suggests that the genes now found in VRE may have originated in glycopeptide-producing bacteria. Our finding that overexpressed, purified, DdlN shows many enzymatic characteristics similar (though not identical) to those of VanA suggests that the genes from glycopeptide-producing bacteria can be important in elucidating biochemical and protein structural aspects of the VRE proteins.
